WELLESLEY HILLS, Mass.--(BUSINESS WIRE)--Point Therapeutics, Inc. (NASDAQ: POTP) today reported financial results for the three and nine month periods ended September 30, 2007. Point reported a net loss of $2,410,000, or $0.06 per basic and diluted share, for the three month period ended September 30, 2007, compared with a net loss of $7,826,000, or $0.24 per basic and diluted share, for the three month period ended September 30, 2006. Point reported a net loss of $10,971,000, or $0.29 per basic and diluted share, for the nine month period ended September 30, 2007, compared with a net loss of $23,028,000, or $0.70 per basic and diluted share, for the nine month period ended September 30, 2006. Point’s cash balance as of September 30, 2007 was $2,311,000.
